Major_spz_x_dwie_belki_gwiazdka_konopie_prod_at... May 2026

: Clear identification of the substance or medicinal product involved.

This "detailed guide" is part of a broader set of that govern pharmacovigilance in the EU. It is specifically tied to Module VI , which handles the collection, management, and submission of reports for suspected adverse reactions. major_spz_x_dwie_belki_gwiazdka_konopie_prod_at...

The phrase appears to be a specific, internal file or code name associated with the European Medicines Agency (EMA) and its Good Pharmacovigilance Practices (GVP) . Specifically, this string is found in the metadata of the detailed guide regarding monitoring medical literature , which outlines the entry of relevant information into the EudraVigilance database. Purpose of the Guide : Clear identification of the substance or medicinal